Tango Therapeutics Inc. (TNGX)
2.75
0.13 (4.96%)
At close: Jan 15, 2025, 3:59 PM
2.62
-4.55%
After-hours Jan 15, 2025, 04:15 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -9.2 | -5.89 | -11.67 | -7.04 | -6.52 |
| PS Ratio | 25.63 | 25.61 | 18.34 | 47.71 | 3.73 |
| PB Ratio | 3.70 | 2.55 | 1.97 | 9.46 | 11.63 |
| P/FCF Ratio | -7.83 | -5.45 | -11.07 | 5.30 | -3.45 |
| P/OCF Ratio | -7.94 | -5.84 | -11.41 | 5.21 | -3.71 |
| OCF/S Ratio | -3.23 | -4.39 | -1.61 | 9.15 | -1.01 |
| Debt / Equity Ratio | 0.15 | 0.16 | 0.00 | 0.20 | 1.00 |
| Quick Ratio | 7.54 | 6.75 | 12.09 | 4.73 | 1.61 |
| Current Ratio | 7.54 | 6.76 | 12.10 | 4.73 | 1.61 |
| Asset Turnover | 0.09 | 0.06 | 0.07 | 0.04 | 0.44 |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.4 | -0.43 | -0.17 | -1.34 | -1.78 |
| Return on Assets (ROA) | -0.25 | -0.25 | -0.12 | -0.25 | -0.25 |
| Return on Capital (ROIC) | -0.32 | -0.29 | -0.13 | -0.31 | -0.51 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -215.38% | 83.80% | 94.69% | 78.77% | -30.93% |
| Net Profit Margin | -278.54% | -435.14% | -157.21% | -677.43% | -57.18% |
| Pretax Profit Margin | -278.18% | -434.92% | -156.43% | -678.84% | -57.18% |
| Operating Profit Margin | -312.57% | -446.79% | -157.09% | -681.82% | -61.51% |
| FCF Margin | -327.18% | -469.72% | -165.66% | 900.84% | -108% |
| EBITDA Margin | -305.96% | -440.32% | -154.67% | -672.44% | -58.9% |